COMPANIES COVERED
RocheDownload FREE Report Sample
Download Free sampleIt is used in the treatment of cancer.
Cancer Drugs Market contains market size and forecasts of Cancer Drugs in global, including the following market information:
Global Cancer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Cancer Drugs companies in 2021 (%)
The global Cancer Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Drugs include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Cancer Drugs Market Segment Percentages, by Type, 2021 (%)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Global Cancer Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Cancer Drugs Market Segment Percentages, by Application, 2021 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Global Cancer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Cancer Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Drugs revenues share in global market, 2021 (%)
Key companies Cancer Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Cancer Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
